Apollomics

Biotechnology - Foster City, California, United States

Apollomics Employees
Yun Ning

Director of Medical Writing

Contact Yun Ning

Peony Yu

Chief Medical Officer

Contact Peony Yu

Elaine Liu

Sr. Director Of Project Development

Contact Elaine Liu

Yan Yu

Senior Director of Clinical Development

Contact Yan Yu

Yufei Chen

Clinical Trial Manager

Contact Yufei Chen

Yash Shenoy

Associate Director Business Development

Contact Yash Shenoy

View All Apollomics Employees Contact All Apollomics Employees
Apollomics Senior Management
Maggie Wang

Executive Assistant to the Chairman of the Board & CEO

Contact Maggie Wang

View All Apollomics Employees Contact All Apollomics Employees
Apollomics Details

Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West.Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates across 12 programs that focus on oncology, of which five (5) drug candidates are at clinical stage. The drug candidates in our existing pipeline can be categorized into three (3) groups based on their mechanisms of action, each of which contains drug candidates at different stages of development. The first group is "tumor inhibitors", which consists of four (4) small molecule inhibitors against different uncontrolled growth signaling pathways in cancer cells, one of which is our Core Product, a c-Met inhibitor. The second group is "anti-cancer enhancers", which could enhance the anti-cancer effects of other treatments. This group comprises two (2) antagonists against a cell adhesion receptor, which are being developed as adjuncts to chemotherapy. The last group is "immuno-oncology drugs", which take the advantage of the body's immune system to fight cancer. This group comprises four (4) drug candidates, including mono-specific and bi-specific antibodies that releases the natural brakes of immune response against cancer cells, as well as a novel cancer vaccine.Having three (3) groups of drug candidates with different mechanisms of action would enable us to develop potential synergistic combination therapies that address unmet needs in cancer treatment.To learn more about Apollomics, visit our website at https://www.apollomicsinc.com/

Apollomics logo, Apollomics contact details
Employees: 11 - 50
HQ:
Location: Foster City, California, United States
Revenue:
Apollomics Technologies
Domain Name Services

Cloudflare DNS

Tag Management

Google Tag Manager

Email Delivery

Amazon SES

Other

Google Maps

Hosting

CloudFlare Hosting

View All Technologies Used At Apollomics

Contacting Apollomics: Connect with Executives and Employees

Get in Touch with Apollomics Executives and Employees

Connecting with Apollomics's Executives and Workforce

Accessing Contact Information for Apollomics Executives

Connecting with Apollomics: Reach Out to Their Team

Discover How to Contact Apollomics Executives and Staff

Looking to connect with Apollomics executives or employees?

Seeking to Get in Touch with Apollomics Executives or Staff?

Want to Reach Out to Apollomics Executives or Team Members?

In Search of Contact Details for Apollomics Professionals?

Connecting with Apollomics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z